GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vivozon Pharmaceutical Co Ltd (XKRX:082800) » Definitions » Operating Cash Flow per Share

Vivozon Pharmaceutical Co (XKRX:082800) Operating Cash Flow per Share : ₩96.20 (TTM As of Jun. 2024)


View and export this data going back to 2005. Start your Free Trial

What is Vivozon Pharmaceutical Co Operating Cash Flow per Share?

Vivozon Pharmaceutical Co's operating cash flow per share for the three months ended in Jun. 2024 was ₩37.06. Vivozon Pharmaceutical Co's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2024 was ₩96.20.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Vivozon Pharmaceutical Co was -99.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -29.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Vivozon Pharmaceutical Co's Operating Cash Flow per Share or its related term are showing as below:

XKRX:082800' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -29.3   Med: -6.3   Max: 25.5
Current: -29.3

During the past 13 years, Vivozon Pharmaceutical Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 25.50% per year. The lowest was -29.30% per year. And the median was -6.30% per year.

XKRX:082800's 3-Year OCF Growth Rate is ranked worse than
85.06% of 783 companies
in the Drug Manufacturers industry
Industry Median: 6.3 vs XKRX:082800: -29.30

Vivozon Pharmaceutical Co Operating Cash Flow per Share Historical Data

The historical data trend for Vivozon Pharmaceutical Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vivozon Pharmaceutical Co Operating Cash Flow per Share Chart

Vivozon Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -185.29 176.52 -536.55 -76.47 62.38

Vivozon Pharmaceutical Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 117,495.00 24.30 39.49 -4.65 37.06

Competitive Comparison of Vivozon Pharmaceutical Co's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Vivozon Pharmaceutical Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vivozon Pharmaceutical Co's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vivozon Pharmaceutical Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Vivozon Pharmaceutical Co's Price-to-Operating-Cash-Flow falls into.



Vivozon Pharmaceutical Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Vivozon Pharmaceutical Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )=Cash Flow from Operations (A: Dec. 2023 )/Shares Outstanding (Diluted Average) (A: Dec. 2023 )
=2991.686/47.957
=62.38

Vivozon Pharmaceutical Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Jun. 2024 )=Cash Flow from Operations (Q: Jun. 2024 )/Shares Outstanding (Diluted Average) (Q: Jun. 2024 )
=1760.036/47.496
=37.06

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩96.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vivozon Pharmaceutical Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Vivozon Pharmaceutical Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Vivozon Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Yongin Techno Valley, 9th and 10th Floor, Building D, Guseong-ro 357, Giheung-gu, Gyeonggi-do, Yongin-si, KOR
Vivozon Pharmaceutical Co Ltd is a global innovative drug development company.

Vivozon Pharmaceutical Co Headlines

No Headlines